NDA 218424, held by Bausch And Lomb Inc. Brimonidine Tartrate.
As of Nov 14, 2026, NDA 218424 (Lumify Preservative Free), held by Bausch And Lomb Inc, was first approved by FDA on Apr 19, 2024, with 0 approved supplements and 0 published complete response letters.
Use relieves redness of the eye due to minor eye irritations
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 19, 2024 | Original applicationNew formulation or manufacturer · Standard review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lumify Preservative Free0.025% · solution/drops;ophthalmic | Brimonidine Tartrate | OTCReference drug |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
